Tenex Health said today it won FDA 510(k) clearance for its TX2 MicroTip designed to treat tendinosis of the shoulder and hip. The Lake Forest, Calif.-based company said that the new TX2 MicroTip is 2 inches longer than the previous TX1 incarnation, allowing for easier access to both the shoulder and hip. “The TX System […]
Tenex Health Inc.
Teleflex taps former Tomotherapy CFO Powell as finance chief | Personnel Roundup
Teleflex (NYSE:TFX) named Thomas Powell CFO effective March 9, replacing Richard Meier, who was ousted the same day.
Powell joined the Limerick, Pa.-based device maker last year as senior vice president of global finance, according to regulatory filings, prior to which he was CFO of TomoTherapy, which was subsequently sold to Accuray (NSDQ:ARAY).
Tenex Health’s $2 million equity round almost complete
Biotech startup Tenex Health Inc. received commitments for $1.7 million in equity of an anticipated $2 million fund-raise, according to a regulatory filing.
The funding, with a minimum of $25,000 per investor, comes from 26 investors, according to the document.
Tenex drums up $1.3 million
By Thomas Lee
Tenex Health Inc. raised $1.3 million from the sale of equity, according to a filing with the Securities & Exchange Commission.
The Rochester, Minn.-based biotech start-up, which is seeking a total of $2 million, is developing treatments for sports-related injuries such as tendinitis.
Founder and CEO Jagi Gill did not return a phone call seeking comment.
